Talal Mohamad Amine El Zarif, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epigenomics | 4 | 2024 | 960 | 1.300 |
Why?
|
Carcinoma, Renal Cell | 9 | 2024 | 3187 | 1.170 |
Why?
|
Kidney Neoplasms | 9 | 2024 | 4282 | 1.050 |
Why?
|
Penile Neoplasms | 1 | 2023 | 158 | 0.790 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2020 | 71 | 0.660 |
Why?
|
Mumps | 1 | 2020 | 71 | 0.650 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2931 | 0.630 |
Why?
|
Telomerase | 1 | 2024 | 751 | 0.620 |
Why?
|
Measles | 1 | 2020 | 180 | 0.590 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13586 | 0.430 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2333 | 0.350 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1761 | 0.350 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2360 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5432 | 0.350 |
Why?
|
Vaccination | 2 | 2021 | 3437 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4058 | 0.300 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4362 | 0.280 |
Why?
|
Receptors, Androgen | 2 | 2022 | 1089 | 0.250 |
Why?
|
Immunotherapy | 4 | 2024 | 4755 | 0.250 |
Why?
|
Melanoma | 1 | 2024 | 5706 | 0.240 |
Why?
|
Mutation | 4 | 2024 | 30238 | 0.230 |
Why?
|
Phenylthiohydantoin | 1 | 2024 | 207 | 0.210 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 154 | 0.200 |
Why?
|
Nephrectomy | 2 | 2024 | 930 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2024 | 580 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 81 | 0.180 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3833 | 0.180 |
Why?
|
Morbillivirus | 1 | 2020 | 3 | 0.180 |
Why?
|
Mumps virus | 1 | 2020 | 23 | 0.180 |
Why?
|
DNA Methylation | 2 | 2024 | 4428 | 0.170 |
Why?
|
Retrospective Studies | 11 | 2024 | 81762 | 0.160 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 454 | 0.160 |
Why?
|
Lebanon | 1 | 2020 | 245 | 0.160 |
Why?
|
Nitriles | 1 | 2024 | 980 | 0.160 |
Why?
|
Benzamides | 1 | 2024 | 1379 | 0.150 |
Why?
|
Neoplasms | 6 | 2025 | 22371 | 0.150 |
Why?
|
Registries | 2 | 2024 | 8375 | 0.150 |
Why?
|
Drug Repositioning | 1 | 2020 | 246 | 0.140 |
Why?
|
Carcinoma, Lobular | 1 | 2021 | 480 | 0.140 |
Why?
|
Male | 16 | 2025 | 364719 | 0.140 |
Why?
|
Myocarditis | 1 | 2025 | 802 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 905 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17569 | 0.130 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2024 | 3556 | 0.130 |
Why?
|
Humans | 28 | 2025 | 768166 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2846 | 0.120 |
Why?
|
Middle Aged | 11 | 2025 | 223492 | 0.120 |
Why?
|
Female | 12 | 2025 | 397192 | 0.110 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1885 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4912 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11878 | 0.100 |
Why?
|
Promoter Regions, Genetic | 1 | 2024 | 5797 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2025 | 2056 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 1351 | 0.100 |
Why?
|
Refugees | 1 | 2020 | 615 | 0.100 |
Why?
|
Databases, Factual | 2 | 2024 | 8080 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1481 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4035 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2024 | 9118 | 0.090 |
Why?
|
Aged | 9 | 2024 | 171504 | 0.090 |
Why?
|
Atherosclerosis | 1 | 2025 | 3433 | 0.080 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2024 | 9419 | 0.080 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8647 | 0.070 |
Why?
|
Treatment Outcome | 5 | 2024 | 65371 | 0.070 |
Why?
|
Cell Differentiation | 1 | 2024 | 11669 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10266 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3503 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10840 | 0.060 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2023 | 28 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12795 | 0.050 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 129 | 0.050 |
Why?
|
Cardiac Imaging Techniques | 1 | 2025 | 280 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 146 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6974 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11101 | 0.040 |
Why?
|
Prednisone | 1 | 2024 | 1567 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36535 | 0.040 |
Why?
|
Mice | 1 | 2024 | 82029 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42669 | 0.030 |
Why?
|
Oncogenes | 1 | 2023 | 1234 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 60066 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1906 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 1003 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1625 | 0.030 |
Why?
|
Adult | 4 | 2024 | 223646 | 0.030 |
Why?
|
Child | 2 | 2020 | 80917 | 0.030 |
Why?
|
Radiosurgery | 1 | 2024 | 1330 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 21206 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1904 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1412 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4146 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6526 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2830 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2726 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3514 | 0.020 |
Why?
|
Animals | 1 | 2024 | 169246 | 0.020 |
Why?
|
Pandemics | 2 | 2022 | 8748 | 0.020 |
Why?
|
Adolescent | 1 | 2020 | 89169 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2491 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4786 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2346 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2025 | 13676 | 0.020 |
Why?
|
Survival Rate | 1 | 2024 | 12840 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3671 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59629 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2025 | 15454 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54926 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15948 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 7073 | 0.020 |
Why?
|
Pediatrics | 1 | 2020 | 3629 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15869 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12168 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 18065 | 0.010 |
Why?
|